Treatment algorithm for intermediate and advanced stage hepatocellular carcinoma: Korea.
about
Liver resection for intermediate hepatocellular carcinomaFate of pulmonary nodules detected by computer-aided diagnosis and physician review on the computed tomography simulation images for hepatocellular carcinomaRole of antiviral therapy in reducing recurrence and improving survival in hepatitis B virus-associated hepatocellular carcinoma following curative resection (Review)Use of (18)F-FDG PET to predict tumor progression and survival in patients with intermediate hepatocellular carcinoma treated by transarterial chemoembolization.Use of Ethanol in the Trans-Arterial Lipiodol Embolization (TAELE) of Intermediated-Stage HCC: Is This Safer than Conventional Trans-Arterial Chemo-Embolization (c-TACE)?Prognostic effect of preoperative sequential transcatheter arterial chemoembolization and portal vein embolization for right hepatectomy in patients with solitary hepatocellular carcinomaBarcelona clinic liver cancer stage B hepatocellular carcinoma: transarterial chemoembolization or hepatic resection?Effects of loco regional treatments before living donor liver transplantation on overall survival and recurrence-free survival in South Korean patients with hepatocellular carcinoma.Preoperative adjuvant transarterial chemoembolization cannot improve the long term outcome of radical therapies for hepatocellular carcinoma.Role of transarterial chemoembolization in relation with sorafenib for patients with advanced hepatocellular carcinoma.Safety and effectiveness of chemoembolization with drug-eluting beads for advanced-stage hepatocellular carcinoma.Treatment of hepatocellular carcinoma: a systematic review.Absence of Benefit of Transcatheter Arterial Chemoembolization (TACE) in Patients with Resectable Solitary Hepatocellular Carcinoma.Clinical parameters predictive of outcomes in sorafenib-treated patients with advanced hepatocellular carcinoma.
P2860
Q26748756-6D2F23B7-2BD1-4398-968E-551B2D0A989BQ34325438-CAA83D6B-1265-4277-80E3-59C15BBAA4E1Q34993924-05AE9D17-6924-43B3-8A81-FA271C0BEC80Q35626234-6C7E211F-43F1-4ABD-AFE8-D00F944DDC92Q35674315-BFFAE87F-E552-4E72-846E-EDF49D2E07C1Q35826267-DACBB63A-2395-4769-A670-DD19900399CEQ36193809-0FD84DC6-8146-470A-A0CB-AF3A3D2B2DE9Q36570317-07A8E80A-9277-4F12-B81D-BC42826A9489Q37623171-E749FAF2-9BE7-4E0F-B73B-1E46F52FAE57Q37687559-AA121EEA-390B-406C-88F1-EF8B946878ADQ38113503-3FF6B852-575C-4C34-9E18-4CECBBD3996FQ38155508-E5480CA4-7812-479C-AF40-A0A5486B8C60Q38419592-1BECDDE1-5F00-4257-8FE4-B8EBAD6762D4Q45275265-3995B208-8FE8-43F9-A801-A30BD123EC92
P2860
Treatment algorithm for intermediate and advanced stage hepatocellular carcinoma: Korea.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Treatment algorithm for intermediate and advanced stage hepatocellular carcinoma: Korea.
@en
Treatment algorithm for intermediate and advanced stage hepatocellular carcinoma: Korea.
@nl
type
label
Treatment algorithm for intermediate and advanced stage hepatocellular carcinoma: Korea.
@en
Treatment algorithm for intermediate and advanced stage hepatocellular carcinoma: Korea.
@nl
prefLabel
Treatment algorithm for intermediate and advanced stage hepatocellular carcinoma: Korea.
@en
Treatment algorithm for intermediate and advanced stage hepatocellular carcinoma: Korea.
@nl
P2860
P356
P1433
P1476
Treatment algorithm for intermediate and advanced stage hepatocellular carcinoma: Korea.
@en
P2093
Jong Young Choi
P2860
P304
P356
10.1159/000333277
P478
81 Suppl 1
P577
2011-12-22T00:00:00Z